Endocrinology & Metabolic Syndrome

Mohamed et al., Endocrinol Metab Synd 2014, 3:1

http://dx.doi.org/10.4172/2161-1017.1000122

Research Article

Open Access

Role of Ghrelin, Leptin and Insulin Resistance in Development of

Metabolic Syndrome in Obese Patients
Waleed S. Mohamed1,2*, Mohammed A. Hassanien2,3 and Khalid EL Sayed Abokhosheim4
Department of Internal Medicine, Faculty of Medicine, Taif University and Tanta University, Egypt
Department of Clinical Biochemistry, Faculty of Medicine, King Abdulaziz and Tanta University, Egypt
3
Department of Clinical Pathology, Faculty of Medicine, Azhar University, Egypt
1
2

Abstract
Objective: Obesity and its complications including metabolic syndrome (MetS) have been increased in children
and adolescents recently. Leptin is known to play an important role in the pathogenesis of obesity. The objective of this
study was to evaluate the relationship between Leptin, Ghrelin and Insulin resistance in the development of metabolic
syndrome in obese persons.
2
. Twenty of them
Methods:
have metabolic syndrome. Body Mass Index (BMI), Waist Circumference (WC), and blood pressure were measured.
Fasting Plasma Glucose (FBG), two hours Post Prandial Blood Glucose (PPBG), Glycated hamoglobin A1C (HbA1c),
triglyceride (TG), Total Cholesterol (TC), high and low density lipoprotein cholesterol (HDL-C and LDL-C), serum

Results:
between plasma Ghrelin and BMI, WC, SBP, DBP, and FBS, PPBG, serum TG, TC, LDL-C, HbA1c, and HOMA-B was
Plasma Ghrelin was positively correlated with HDL-C while Leptin was positively correlated with it in obese and MetS
correlation between plasma insulin and leptin in obese and MS groups.
Conclusion: There are hormonal changes associated with clusters of metabolic abnormalities and elevation of
blood pressure that may have a role in the development of MetS in obese persons and are major CHD risk factors.
Insulin has stimulatory trophic effect on leptin secretion, but the effect of leptin on insulin is controversial as leptin may
modulate insulin action and participates in the development of insulin resistance. As regard Ghrelin secretion, there
are many suppressive factors: insulin, Leptin and glucose. Our study produces a preliminary result, thus further studies
with large number of patients are required.

Keywords: Ghrelin; Leptin; Insulin resistance; Obesity and metabolic

syndrome

Introduction
Obesity is generally recognized as an increasingly important cause of
childhood and adolescent morbidity worldwide and is a contributor to
chronic diseases such as type 2 diabetes mellitus (T2DM) and Coronary
Heart Disease (CHD) [1]. Obesity has central role in Metabolic Syndrome
(MetS). MetS has appeared with increasing frequency in children and
adolescents, driven by the growing pediatric obesity epidemic [1,2].
Behavioral factors such as poor dietary habits, a sedentary lifestyle, and
a social environment which encourages unhealthy behaviors are closely
correlated with the prevalence of obesity and MetS in adolescents [3].
MetS is characterized by a clustering of metabolic abnormalities which
leads to increased cardiovascular disease and all-causes mortality. The
five generally accepted features of metabolic syndrome are obesity,
insulin resistance, dyslipidemia [including increased triglycerides and
decreased HDL], impaired glucose tolerance, and hypertension [4].
Recent studies suggest that MetS may be associated with subsequent
risk of T2DM and CHD in young population, particularly in the
overweight or obese. Considering recent global rise of childhood
obesity prevalence, the overall prevalence of the metabolic syndrome
in children and adolescents seems to be higher than what is estimated
from previous studies [5].
Leptin is a peptide produced by differentiated adipocytes. It is
thought to be a key hormone in the regulation of body fat stores. This
peptide controls energy metabolism at the level of hypothalamus by
supporting the food intake and stimulating energy expenditure [6]. The
Endocrinol Metab Synd
ISSN: 2161-1017 EMS, an open access journal

relationship between serum Leptin and body mass index has been well
established [7]. Leptin is also proposed to be associated with insulin
resistance and diabetes in human [8]. However, potential relationship
between metabolic syndrome and leptin has not been sufficiently
addressed in previous studies, particularly in children [9]. Ghrelin
is a novel 28-amino acid residue peptide hormone predominantly
produced by the stomach. Substantially lower amounts were detected
in bowel, pancreas, kidneys, the immune system, placenta, testes,
pituitary, lung, and hypothalamus [10]. Ghrelin displays strong Growth
Hormone (GH)-releasing activity, which is mediated by the activation
of the so-called GH secretagogue (GHS) receptor type la (GHS-R
la) [11]. At the hypothalamic level, Ghrelin acts via mediation of
GHRH-secreting neurons as indicated by pretreatment with GHRH
antagonists, reduces their stimulatory effect on GH secretion [12].
An increased release of GHRH in portal blood of the pituitary after

*Corresponding author: Waleed S Mohamed, Internal Medicine Department, Tanta

[email protected]
Received

Accepted

Published January

Citation: Mohamed WS, Hassanien MA, Sayed Abokhosheim KEL

Ghrelin, Leptin and Insulin Resistance in Development of Metabolic Syndrome in
Obese Patients. Endocrinol Metab Synd 3: 122. doi:
2
Copyright:
Mohamed WS, et al.. This is an open-access article distributed
under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the
original author and source are credited.

Volume 3 Issue 1 1000122

Citation: Mohamed WS, Hassanien MA, Sayed Abokhosheim KEL

Syndrome in Obese Patients. Endocrinol Metab Synd 3: 122. doi:

Page 2 of 6

Ghrelin administration has also been shown in animals [13]. Ghrelin

enhances appetite and increases food intake by increasing agoutirelated protein (AGRP) and neuropeptide Y (NPY) expression in the
hypothalamus. Also, it reduces fat utilization and causes adiposity in
rodents. The release of Ghrelin may stimulate the release of orexigenic
peptides and neurotransmitters, thus representing a novel regulatory
circuit controlling energy homeostasis and neurotransmitters release
[14]. Ghrelin is able to modify glucose and insulin metabolism, blood
adipogenesis and inflammatory processes in experimental conditions
[15].
The present study aims to evaluate such a relationship between
plasma leptin, Ghrelin and insulin resistance with the development of
metabolic syndrome in obese patients.

Patients and Methods

The present study was carried out on fifty obese persons (obesity
was defined according to WHO criteria 2010 as BMI greater than or
equal to 30 kg/m2) with matched age range 24-45 years 20 of them
has metabolic syndrome selected from Outpatient Clinics of Internal
Medicine Department, Tanta University Hospital. The metabolic
syndrome was diagnosed according to WHO criteria. Fifteen apparently
healthy volunteers hospital staff with average body weight (7 female, 8
male), with matched age range 34-52 years, and were enrolled in the
study as a control. Persons with a waist circumference equal to or above
90 percentile of their age and height were invited to attend to participate
in the study. All persons had similar lifestyle with no significant physical
training program before beginning the study.

Exclusion criteria
-Persons with a known history of primary hyperlipidemia, diabetes
or secondary obesity.
-Patients receiving medication that could affect the metabolic
profile (e.g., beta blocker, steroids and diuretics).
- Menopausal women.

After their consent, all subjects were subjected to:

1- Full history taking with particular emphasis on age, family
history, history of any systemic diseases e.g. diabetes, hypertension,
dyslipidemia or history of any associated diseases and any drug intake.
2- Thorough clinical examination with special stress on:
-Systolic and diastolic blood pressure (SBP & DBP).
- Body weight was measured to the nearest 0.5 Kilograms (kg) with
subjects barefooted and wearing light indoor clothes. Body height was
recorded to the nearest 0.5 centimeter (cm).
- BMI was calculated as the ratio of body weight to body height
squared expressed as Kg/m2.
- Waist circumference (WC) was measured at the distal third of the
line from the xyphoid process to the umbilicus.
Participants were classified to overweight or obese using
international sex and age specific BMI cut-offs recommended by the
International Obesity Task Force (IOTF) [9].

Blood sampling and analysis

After overnight fasting, 7 ml blood was collected from a vein in
the antecubital fosse between 8 and 9 AM after overnight fasting
in clean tubes. 1.8 ml were collected in EDTA tube and preserved at

Endocrinol Metab Synd

ISSN: 2161-1017 EMS, an open access journal

refrigerator after gentle mix for assay of Hb A1c. The other 5.2 ml were
collected in plain tube, incubated for 20 minutes, then centrifuged
at 3000 rpm for 10 minutes .Serum was separated in another clean
tube and stored at -20 till the assay time. Fasting and two hours post
prandial blood glucose was measured according to glucose-oxidase
method [16]. Glycated hamoglobin A1C was measured using a column
chromatography method by commercial kit provided from Biosystem
Company. After final elution the result was determined photometrically
using Biosystem photometer (Reference range 5.1-6.4%). Serum
triglycerides (TG), Total Cholesterol (TC) and high density lipoprotein
(HDL cholesterol).were measured photo metrically using commercial
kit provided from Spinreact, and LDL was calculated by the equation
(LDL=cholesterol - triglycerides/5 HDL).
Insulin level: was estimated according to Angel (1988) [17] using
a commercially available ELISA kit which was modified for use in
microtiter plates. The adapted assay, is based on the binding of porcine
anti-guinea pig insulin antibodies to microtiter plates and uses insulinperoxidase conjugate as displacer.
Serum ghrelin level: was measured by a commercially available
ELISA kit (The DSL- 10-33700) Human Ghrelin ELISA Kit; Diagnostic
System laboratories, Webster, Texas). This assay is an enzymatically
amplified one-step sandwich-type irnmunoassay. In the assay,
standards, controls and unknown plasma samples are incubated with
antighrelin antibody in microtitration wells which have been coated
with another anti-Ghrelin monoclonal antibody. After incubation and
washing, the wells are incubated with the substrate tetramethylbenzidine
(TMB), an acidic stopping solution is then added and the degree of
enzymatic turnover of the substrate is determined by dual wavelength
absorbance measurement at 450 and 620 nm. The absorbance measured
is directly proportional to the concentration of total Ghrelin present.
A set of total Ghrelin standards is used to plot a standard curve of
absorbance versus total Ghrelin concentration from which the total
Ghrelin concentrations in the samples were calculated [18].
Serum leptin level: was measured by a commercially available
ELISA kit (The DSL- 10-23100 Human Leptin ELISA Kit; Diagnostic
System laboratories, Webster, Texas). This assay is a direct Sandwich
ELISA based, sequentially, on capture of human leptin molecules from
samples to the wells of a microtiter plate coated by pre-titered amount
of polyclonal rabbit anti-human leptin antibodies, and wash away of
unbound materials from samples, then, binding of a biotinylated
monoclonal antibody to the captured human leptin, and conjugation of
alkaline phosphatase to biotinyiated antibodies, after that, wash away of
free antibody-enzyme conjugates.
Finally, quantification of immobilized antibody-enzyme conjugates
by monitoring alkaline phosphatase activities in the presence of the
substrate p-nitrophenyl phosphate. The enzyme activity is measured
spectrophotometrically by the increased absorbency at 405 nm due
to production of the yellow colored product p-nitrophenol. Since
the increase in absorbency is directly proportional to the amount of
captured human leptin in the unknown sample, the latter can be
derived by interpolation from a reference curve generated in the same
assay with reference standards of known concentrations of human
leptin [19].
Homeostasis model assessment: HOMA is an arithmetic way
of deriving indices of pancreatic endocrine function HOMA- and
HOMA-IR from fasting plasma samples [20]. This model assumes
that plasma glucose and insulin in the fasting state is controlled by a
feedback loop between the pancreas, liver, and insulin-sensitive and
insulin-insensitive peripheral tissues. HOMA correlates well with and

Volume 3 Issue 1 1000122

Citation: Mohamed WS, Hassanien MA, Sayed Abokhosheim KEL

Syndrome in Obese Patients. Endocrinol Metab Synd 3: 122. doi:

Page 3 of 6

is validated against the gold standard methods of assessment of these

functions, such as the euglycemic hyperinsulinemic clamp [21].

Control group Obese group

n = 15
n = 30
M

HOMA-IR and HOMA- are derived using the formulae:

Insulin (mU/mL)

HOMA-IR = [glucose (mg/dL) insulin (mU/l)] / 405

Leptin (ng/mL)

HOMA- = [360 insulin (mU/l)] / [glucose (mg/dL) 63)]

Ghrelin ( pg/ml)

IRis insulin resistance and% is the -cell function. Glucose and

insulin are both during fasting. In an ideal reference population of
young, healthy subjects HOMA- and HOMA-IR are 100% and 1
(arbitrary units), respectively.

Statistical Analysis

Results
Table 1 showed basic clinical data of the studied groups, patients
with metabolic syndrome were significantly more obese than others.
There is no significant difference between studied groups as regard
age and gender. WC, BMI, SBP and DBP were significantly increased
Control group
n = 15
M

SD

Obese group
n = 30
M

SD

MS Group
n = 20
M

SD

Age (year)
Sex M/F

NS

BMI (kg/m2)

2.2

WC (cm)
SBP
DBP

Table 1: Basic clinical data of the studied groups.

Control group
n = 15
M

SD

Obese group
n = 30
M

SD

FBG (mg/dl)

11.3

PP BG (mg/dl)

13.3

MS Group
n = 20
M

SD

HbA 1c (%)
HOMA-IR

Cholesterol
(mg/dl)
TG (mg/dl)

33.1

22.3

LDL - C (mg/dl)
HDL - C (mg/dl)

Table 2: Laboratory data of the studied groups.

Endocrinol Metab Synd

ISSN: 2161-1017 EMS, an open access journal

SD

SD

22.1

3.3

Table 3: Hormonal results of the studied grou

BMI
Ghrelin
Leptin

Values were expressed as mean SD. The statistical analysis of the

results was carried out according to the conventional standard statistical
procedures using computed statistical analysis by SPSS, version 20.0
for Microsoft Windows XP. All variables were tested for normality of
distribution, Fishers exact test; independent samples t-test (t value) and
ANOVA was applied to detect the difference between two arithmetic
means and linear regression correlation. P values less than 0.05 were
considered significant.

SD

MS Group
n = 20

WC

SBP

DBP

Table 4: Correlation between Ghrelin and leptin with clinical data of obese and
MS group.
FBG
Ghrelin
Leptin

PPBG

HOMA-S

HOMA-B

HbA1c

Table 5: Correlation between Ghrelin and leptin with blood glucose and HOMA-S
and HOMA-B in obese and metabolic syndrome group.
Triglyceride
Ghrelin
Leptin

Cholesterol

HDL C

LDL C

Table 6:
metabolic syndrome group.

in obese and MetS groups compared to control group (p<0.0001)

with significant difference between obese and MetS groups. Table 2
shows laboratory data of the studied groups, FBS, PPBG and HbA1c
were significantly increased in obese and MetS groups compared to
control group with a significant difference between obese and MetS
groups (p<0.0001). HOMA-IR, was increased in obese and MetS
groups with a significant difference only between control and MetS
groups (p=0.0073). HOMA- was significantly increased in obese and
MetS groups compared to control group (p=0.002) with no significant
difference between obese and MetS group.
As regards lipid profile (Table 2), there was a significant increase
of serum TG, TC and LDL cholesterol (p<0.0046, 0.0001 & 0.0001
respectively) in obese and MetS compared to control group with a
significant difference between obese and MetS groups. As regards
serum TC and TG. There was a significant decrease in the level of HDL
cholesterol in obese and MetS groups (p<0.0001) compared to control
group with no significant difference between obese and MetS group.
Table 3 shows a significant increase of insulin and leptin (p<0.0001)
while Ghrelin is significantly decreased in obese and MetS groups
compared to control group (p<0.0001). Table 4 reveals a significant
negative correlation between plasma Ghrelin and BMI (r=-0.7506), WC
(r=-0.5616), SBP (r=-0.5464) and DBP (r=-0.6050) while leptin showed
a significant positive correlation with them (r=0.5944, 0.5643, 0.3839&
0.4250 respectively).
Table 5 showed a significant negative correlation between plasma
Ghrelin and FBS (r=-0.7024), PPBG (r=-0.6787), HbA1c (r=-0.6671),
and HOMA-B (r=-0.4514) while leptin showed significant positive
correlation with FBS (r=0.4774), PPBS (r= 0.5260), HbA1c (r=0.4943),
and HOMA- (r=0.4637) and significant negative correlation with
HOMA-IR (r=-0.3694). In Table 6 there was a significant negative

Volume 3 Issue 1 1000122

Citation: Mohamed WS, Hassanien MA, Sayed Abokhosheim KEL

Syndrome in Obese Patients. Endocrinol Metab Synd 3: 122. doi:

Page 4 of 6
Ghrelin

Leptin

Insulin
Leptin

-------

Table 7: Correlation between Ghrelin and leptin with insulin in obese and metabolic
syndrome group

correlation between plasma Ghrelin and serum TG (r=-0.5291),

cholesterol (r=-0.4768) and LDL cholesterol (r=-0.6695) with a positive
correlation with HDL cholesterol (r=0.6135). Leptin showed significant
positive correlation with serum TG (r= 0.3609), TC (r= 0.3170) and
LDL cholesterol (r=0.5005) with significant negative correlation with
HDL cholesterol (r=- 0.4346) in obese and MetS groups. Table 7 showed
a significant negative correlation between plasma Ghrelin and insulin
and leptin (r=-0.6452& -0.7253 respectively) with a significant positive
correlation between plasma insulin and leptin (r=0.5174) in obese and
MS groups.

Discussion
Obesity is generally recognized as an increasingly important cause
of morbidity worldwide and contribute to chronic diseases such as
T2DM and CHD [1]. MetS a clustering of obesity, impaired glucose
metabolism, hypertension, and dyslipidemia, has been shown to be
predictive for the development of diabetes and CHD in this young
population, particularly in the overweight or obese [5]. In the present
study, there were significant increases in BMI, WC, SBP, DBP, FBS, PP
BS and HbA1c in obese and Mets groups compared to control group.
This in agreement with Yoon et al. [22], who found that MetS was
positively associated with body weight, waist circumference, blood
pressure and blood glucose levels.
HOMA-IR, is increased in obese and MetS groups with a significant
difference only between control and MetS groups (p=0.0073). HOMA is significantly increased in obese and MetS groups compared
to control group (p=0.002) with no significant difference between
obese and MetS group. Garg et al. [23] found that subjects with MetS
had more insulin resistance (HOMA-IR) and less insulin secretion
(HOMA-) than healthy controls. Yoon et al. [22] who found that MetS
was positively associated with the HOMA-IR. As regards lipid profile,
there was a significant increase in serum triglyceride, cholesterol and
LDL cholesterol in obese and MS groups compared to control group
with a significant difference between obese and MS groups with respect
to serum cholesterol and triglyceride. There was a significant decrease
in HDL cholesterol in obese and MetS groups (p<0.0001) compared to
control group with no significant difference between obese and MetS
group. This in agreement with Yoon et al. [22] who found that MetS
was positively associated with TC, TG and negatively associated with
the HDL-cholesterol level. The degree of correlation between the MetS
score and TG level was highest, followed by that with HDL cholesterol.
Our study revealed significant increase in serum Insulin and
Leptin hormones concentrations in obese and MetS groups compared
to control group. More evidence emerges that insulin can regulate
Leptin expression. This is most evident from studies on isolated
adipocytes, which showed that in vitro insulin clearly stimulates the
mRNA expression and secretion of Leptin in cultured rat and human
adipocytes. Another possibility, glucose metabolism seems to be an
important determinant of Leptin expression and secretion. In human
experiments, hyperinsulinaemia induced by clamp techniques leads
to a rise in leptin concentrations [24]. One report on a patient with
insulinoma reported markedly elevated leptin levels during chronic high
insulinaemia, which both dropped after surgical removal [25]. High

Endocrinol Metab Synd

ISSN: 2161-1017 EMS, an open access journal

leptin concentrations may in part be influenced by hyperinsulinemia

or impaired insulin sensitivity. This in agree with our results where
HOMA-IR, was significantly decreased while, HOMA- was nonsignificantly increased in obese and MetS groups compared to control
group. Leptin showed significant positive correlation with HOMA-
and significant negative correlation with HOMA-IR.
In the present study, we observed a significant decrease in plasma
Ghrelin concentration in obese and MetS groups compared to control
group. The exact mechanism of decreasing Ghrelin secretion is not fully
understood. There are many possibilities: the first one, hyperinsulinaemia
is an inhibitor of Ghrelin secretion [26]. The mechanism of inhibitory
effect of insulin on Ghrelin secretion is unclear. The gastrointestinal tract
can be regarded as an insulin-sensitive tissue; therefore, the insulin
mediated decrease in plasma Ghrelin could result from inhibition of
Ghrelin release in the stomach cells [27]. The second possibility, there
is substantial evidence that leptin can exert an inhibitory effect on
gastric Ghrelin release [28]. Leptin has satietyinducing effects which
include suppression of gastric orexigenic signals and disruption of
a potential feedback mechanism between body weight changes and
plasma Ghrelin in lean adult rats [29]. This is in agreement with our
results where there were increase in plasma insulin and leptin in obese
and MetS groups. The third possibility, reduction of plasma Ghrelin
level may be associated with higher BMI [30]. This is agreement with
our results where Ghrelin was significantly lower in obese and MetS
groups compared to control group with a negative correlation between
Ghrelin and BMI, WC, SBP and DBP. Some studies revealed that low
Ghrelin was associated with the prevalence of hypertension [31] in
some human studies, fasting plasma Ghrelin negatively correlated with
BMI. The fourth possibility, suppression of plasma Ghrelin level may be
due to hyperglycemia in T2DM patients [32]. This in accordance with
our data where obese and MetS groups had higher blood glucose and
Insulin levels suggesting that hyperinsulinemia associated with insulin
resistance decreases serum levels of Ghrelin in obese patients. Also,
there was a negative correlation between serum Ghrelin and FBS, PPBS,
HbA1c and HOMA- with positive correlation with HOMA-IR while
there was a negative correlation between plasma Ghrelin and insulin
level and leptin.
Leptin showed significant positive correlation with BMI, WC,
SBP and DBP in obese and MetS groups. This in agreement with Adil
Omar et al. [33] who found that Leptin concentrations were high in
both obese and diabetic obese group and showed a direct positive
relation with BMI and waist circumference. Anoop and Jie [34] found
that, higher plasma leptin levels are associated with hypertension both
among women as well as men in a representative sample of adults.
Leptin showed significant positive correlation with FBS, PPBS, HbA1c,
and HOMA- with significant negative correlation with HOMA-IR.
Maria et al. [35] stated that elevated serum leptin, particularly in obese
individuals, should be taken as a warning sign of energy imbalance,
poor diet, hyperinsulinemia, insulin resistance, or changes in other
metabolic risk factors that are strongly associated with cardiovascular
disease and T2DM. Leptin receptors are present on human hepatocytes,
and Leptin was shown to modulate several insulin induced activities in
these cells. Leptin antagonizes insulin signaling by decreasing insulininduced tyrosine phosphorylation of Insulin Receptor Substrate
(IRS), it increases phosphoenolpyruvate-carboxykinase and decreases
glucokinase expression leading to increased gluconeogenesis and
decreased glycolysis [36]. The hepatic effects of high Leptin levels may
thus contribute to hepatic insulin resistance. Some studies indicate that
Leptin is able to modulate insulin action (on glucose uptake and/or
lipid synthesis) in adipocytes and muscle cells, but other studies found
no effect on peripheral glucose uptake [37]. Leptin may acts at different

Volume 3 Issue 1 1000122

Citation: Mohamed WS, Hassanien MA, Sayed Abokhosheim KEL

Syndrome in Obese Patients. Endocrinol Metab Synd 3: 122. doi:

Page 5 of 6

intracellular levels, including transcription to membrane permeability

to inhibit insulin synthesis as well as secretion. Functional Leptin
receptors also present on insulin-secreting pancreatic -cells [38]. The
insulin-lowering effect of Leptin administration could thus be mediated
through these receptors. Recently, a direct effect of Leptin on insulin
gene transcription in pancreatic -cells was shown, with a reduction of
preproinsulin mRNA by 50% [39]. On the other hand, impaired insulin
sensitivity may both induce increased insulin levels and lead to raised
Leptin levels by down-regulation of the hypothalamic Leptin receptors
or the subsequent satiety response to Leptin. Insulin resistance has been
investigated as a potential CHD risk factor in the general population
[40]. This in agreement of our results where a significant positive
correlation between insulin and Leptin was found.

11.
Neuroendocrine and peripheral activities of ghrelin: implications in metabolism
12.
Ghrelin on growth hormone secretion from cultured adenohypophysial cells in
13.
hormone (GH)-releasing hormone secretion is stimulated by a new GH-

As regard lipid profile, there was a significant negative correlation

between plasma Ghrelin and serum TG, TC and LDL cholesterol
with a positive correlation with HDL cholesterol while Leptin showed
significant positive correlation with serum TG, TC and LDL cholesterol
with significant negative correlation with HDL cholesterol. Hiroshi et
al. [41] found that Leptin was positively correlated with SBP, DBP, FPG,
TC, TG, LDL-C and and negatively correlated with HDL-C. Al-Hakeim
and Ali [42] found that Ghrelin levels were negatively correlated with
BMI.
In conclusion, there are hormonal changes associated with clusters
of metabolic abnormalities and elevation of blood pressure that may
have a role in the development of MetS in obese persons and are major
CHD risk factors. Insulin has stimulatory trophic effect on leptin
secretion, but the effect of leptin on insulin is controversial as leptin
may modulate insulin action and participates in the development of
insulin resistance. With regard to Ghrelin secretion, there are many
suppressive factors: insulin, Leptin and glucose. Our study produces a
preliminary result, thus further studies with large number of patients
are required.

distribution and mechanism of action of ghrelin in the CNS demonstrates a

measurement of plasma levels of acylated and desacyl ghrelin in healthy

Development of a sensitive ELISA for human leptin, using monoclonal

Homeostasis model assessment: insulin resistance and beta-cell function from

21.
Homeostasis model assessment closely mirrors the glucose clamp technique
in the assessment of insulin sensitivity: studies in subjects with various degrees

Acknowledgment
The authors are grateful to the staff of the Endocrinology and Diabetes Unit,
Internal Medicine Department, Tanta Faculty of Medicine, Egypt.

22.
between metabolic syndrome score and severity of coronary atherosclerosis as
assessed by angiography in a non-diabetic and diabetic Korean population. J

References
1.
and adolescence: more than just diabetes. Curr Opin Endocrinol Diabetes

23.

2.
and obesity in relation to insulin resistance syndrome components among
school children in Taiwan--The Taipei Children Heart Study. Int J Obes Relat
Leptin levels do not change acutely with food administration in normal or
obese subjects, but are negatively correlated with pituitary-adrenal activity. Clin

3.
issues and challenges. Appl Physiol Nutr Metab 32: 13-22.

hypothalamic insulin receptors causes hyperphagia and insulin resistance in

Obesity and the metabolic syndrome in children and adolescents. N Engl J

insulin treatment in type 2 diabetic patients on intracellular lipid content in liver

correlate with obesity parameters but not with hyperinsulinism in women with

prevents increased plasma ghrelin concentration during short-term moderate

association of basal and postprandial plasma ghrelin with leptin, insulin, and
between high plasma leptin concentrations and metabolic syndrome in obese

Endocrinol Metab Synd

ISSN: 2161-1017 EMS, an open access journal

31.

Volume 3 Issue 1 1000122

Citation: Mohamed WS, Hassanien MA, Sayed Abokhosheim KEL

Syndrome in Obese Patients. Endocrinol Metab Synd 3: 122. doi:

Page 6 of 6
Low plasma ghrelin is associated with insulin resistance, hypertension, and the

Intracerebroventricular leptin regulates hepatic but not peripheral glucose

32.
ghrelin levels in lean and obese humans and the effect of glucose on ghrelin
33.
Mass Index and Waist Circumference in Saudi Female Population of the

and body mass and metabolic syndrome in an adult population]. Rev Port

between baseline serum leptin levels and 2-year changes in body mass index,
blood pressure and metabolic parameters in Japanese male adolescents and

control and bad prognosis parameters in obese diabetic patients. Journal of

Submit your next manuscript and get advantages of OMICS

Group submissions
Unique features:

User friendly/feasible website-translation of your paper to 50 worlds leading languages

Audio Version of published paper
Digital articles to share and explore

Special features:

Citation: Mohamed WS, Hassanien MA, Sayed Abokhosheim KEL

Role of Ghrelin, Leptin and Insulin Resistance in Development of Metabolic
Syndrome in Obese Patients. Endocrinol Metab Synd 3: 122. doi:
2

Endocrinol Metab Synd

ISSN: 2161-1017 EMS, an open access journal

300 Open Access Journals

25,000 editorial team
21 days rapid review process
Quality and quick editorial, review and publication processing
Indexing at PubMed (partial), Scopus, EBSCO, Index Copernicus and Google Scholar etc
Sharing Option: Social Networking Enabled
Better discount for your subsequent articles

Submit your manuscript at: http://www.omicsonline.org/submission/

Volume 3 Issue 1 1000122